Comparison of Myofascial Release and Mulligan Concept Techniques in Patients With Cervicogenic Headache

March 24, 2026 updated by: fatih bali, Istanbul Medipol University Hospital

Effectiveness of Myofascial Release and Mulligan Concept Techniques in Patients With Cervicogenic Headache: A Single Blind-Randomized Clinical Trial

The International Headache Society classifies cervicogenic headache as a secondary headache caused by a disorder of the cervical spine and its components. Mulligan Concept (SNAG) is a gentle manual therapy that can be applied to the neck area. The myofascial release technique is also a massage-type manual therapy technique that is widely used in physiotherapy to relieve pain and tension in the relevant muscle group.

This clinical trial aims to investigate the effectiveness of the Mulligan Concept and myofascial release technique in patients with cervicogenic headaches. The main questions it aims to answer are:

  1. Does the Mulligan Concept improve hand grip strength, pressure pain threshold, range of motion, pain frequency, pain intensity, pain duration, number of medications used, daily living activities, and disability in patients with cervicogenic headache?
  2. Does myofascial release technique improve hand grip strength, pressure pain threshold, range of motion, pain frequency, pain intensity, pain duration, number of medications used, daily living activities, and disability in patients with cervicogenic headache?

Researchers will compare the Mulligan Concept to a myofascial release technique to see which physiotherapy method has more significant results in treating cervicogenic headaches.

Participants will:

  • Undergo the evaluations mentioned above before and after interventions
  • Undergo Mulligan Concept applications or the myofascial release technique 3 times a week for 4 weeks
  • Keep a diary of their symptoms and the number of times they use a drug

Study Overview

Detailed Description

Although headache is one of the most common neurological symptoms, it is still not fully recognized and treated worldwide. The International Headache Society divides headaches into primary and secondary categories. The International Headache Society classifies cervicogenic headache as a secondary headache caused by a disorder of the cervical spine and its components. The prevalence in the general population is estimated to be approximately 0.17% to 4.1%.

Cervicogenic headache features are as follows;

  1. observed in adulthood,
  2. unilateral and does not change sides,
  3. radiating from the back of the head and neck to the ear and cheekbone,
  4. can be triggered mechanically by maneuvers,
  5. characterized by compressive pain that starts seconds or 30 minutes after the maneuver and lasts for several days to weeks

The diagnostic criteria for cervicogenic headache are as follows:

  1. The headache developed at a time similar to the onset of the cervical disorder or the appearance of the lesion
  2. The headache has significantly decreased or disappeared in parallel with the regression or complete healing of the cervical disorder or lesion
  3. The cervical range of motion is reduced and the headache worsens significantly with stimulating maneuvers
  4. The headache disappears after the cervical structure or nerve source is blocked for diagnosis

Studies show that physiotherapy and rehabilitation approaches such as manual therapy, exercise training, and dry needling are effective in treating headaches.

Studies have shown that people with cervicogenic headaches have a high rate of C1-C2 dysfunction. The mechanism of Mulligan's movement mobilization technique (SNAG) is based on the correction of joint position. Mulligan's SNAG technique is a gentle manual therapy method. Some studies have shown that Mulligan mobilization increases the range of motion and significantly reduces pain intensity and frequency in patients with cervicogenic headaches

Another form of massage-type manual therapy, myofascial release, is widely used in clinical practice. Previous studies have found that active myofascial trigger points often trigger tension-type headaches and migraines with palpation. Therefore, treatment of these myofascial trigger points may be an effective headache management.

In light of the literature data, this study aims to investigate and compare the effectiveness of physiotherapy methods such as Mulligan Concept applications and myofascial release technique on hand grip strength, pressure pain threshold, range of motion, pain frequency, pain intensity, pain duration, number of medication use, daily living activities and disability in patients with cervicogenic headache.

Hypotheses of this study are;

H0: There is no significant difference in favor of myofascial release technique or Mulligan concept applications in terms of pressure pain threshold, neck joint range of motion, handgrip strength, pain intensity, frequency and duration, number of medications used, disability and daily living activities between myofascial release technique and Mulligan concept applications in cervicogenic headache.

H1: There is a significant difference in favor of myofascial release technique between myofascial release technique and Mulligan concept applications in terms of pressure pain threshold, neck joint range of motion, handgrip strength, pain intensity, frequency and duration, number of medications used, disability and daily living activities between myofascial release technique and Mulligan concept applications in cervicogenic headache.

H2: There is a significant difference in favor of Mulligan concept applications between myofascial release technique and Mulligan concept applications in terms of pressure pain threshold, neck joint range of motion, handgrip strength, pain intensity, frequency and duration, number of medications used, disability and daily living activities.

To determine whether the physiotherapy approach produces greater significant outcomes for treating cervicogenic headaches, researchers will compare the Mulligan Concept with a myofascial release technique.

The 40 individuals, consisting of women and men, who will participate in the study will be randomly divided into two groups. These groups will consist of individuals who receive the myofascial release method or the Mulligan concept technique. After the initial evaluations, both groups will be applied to a 4-week treatment program consisting of 3 sessions per week and the evaluations will be repeated at the end of the 4 weeks. The researcher who makes the evaluations will not know which treatment the individuals received, in other words, will be blind to the groups.

The participants will be evaluated on their neck joint range of motion, pressure pain threshold, hand grip strength, headache and functionality, and disability due to neck problems. In addition, they will be evaluated on their pain frequency, intensity, and duration. Participants will keep a diary of their symptoms and the number of times they use a medication.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Istanbul
      • Istanbul, Istanbul, Turkey (Türkiye), 34295
        • Sefakoy Medipol University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having been diagnosed with cervicogenic headache according to the International Classification of Headache Disorder-III diagnostic criteria
  • Having been diagnosed with cervicogenic headache for more than 3 months
  • Having a headache accompanying neck pain
  • Having restricted neck joint movement according to the Flexion-Rotation Test
  • Having pain between 3 and 8 according to the Visual Analog Scale
  • Being between 25-60 years of age
  • Agreeing to participate in the study voluntarily

Exclusion Criteria:

  • Previous cervical surgery
  • Previous cervical trauma
  • Having received diagnosis-related physiotherapy in the last 6 months
  • Diagnosis of tumor or cancer
  • Having other types of headache
  • Serious cardiovascular, cerebrovascular, hematological, metabolic, neurological or mental disease
  • Being pregnant or breastfeeding
  • Having red flags for manual therapy
  • Dizziness with headache, visual disturbance
  • Congenital cervical disorder
  • Rheumatoid arthritis, cervical spondylolisthesis, cervical instability, infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Myofascial Release Group
Twenty participants who will be randomized into the myofascial release group will undergo the myofascial release technique by an experienced physiotherapist 3 times a week for 4 weeks.
Myofascial therapy can be described as massage-type manual therapy. The participants of the Myofascial Release Group will undergo the myofascial release technique.
Experimental: Mulligan SNAG group
Twenty participants who will be randomized into the Mulligan SNAG group will undergo the Mulligan SNAG technique by an experienced physiotherapist 3 times a week for 4 weeks.
The participants of the Mulligan SNAG group will undergo the Mulligan SNAG technique. Mulligan's SNAG technique is a gentle manual therapy method. This technique is based on the correction of the joint position. There are 3 techniques specified for headache; Headache SNAG, Reverse Headache SNAG, and C1-C2 SNAG.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Headache Impact Test-6
Time Frame: 10 minutes
Headache Impact Test-6 (HIT-6) evaluates the effects of headaches on daily living activities. HIT-6 shows good internal consistency, retest reliability, validity and responsiveness. A total score of 36 is the best in terms of headache, and 78 is the worst. In this study, HIT-6 will be used to evaluate how headache affects individuals' daily living activities.
10 minutes
Hand Grip Strength Measurement
Time Frame: 1 minute
To the best of our knowledge, no previous study has evaluated the effect of headache on handgrip strength. However, studies have shown a negative correlation between neck pain and handgrip strength. The Jamar Hand Dynamometer is the gold standard tool for handgrip strength assessment in clinical and research settings with its validity and reliability. In this study, Jamar dynamometer will be used to evaluate the hand grip strength of patients on the affected side.
1 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle Tone Measurement
Time Frame: 5 minutes
In this study, MyotonPro will be used to evaluate the effect of physiotherapy techniques on muscle tone. MyotonPRO offers a non-invasive, reliable and accurate solution for digital palpation of soft biological tissues. The device measures superficial skeletal muscles, tendons, ligaments, adipose tissue and skin. MyotonPRO is a hand-held, smartphone-sized device which is quick and easy to use. Scientific research has proven its practicality and versatility.
5 minutes
Cervical Range of Motion Measurement
Time Frame: 5 minutes
A reduction in the cervical joint range of motion is frequently observed in cervicogenic headaches. A digital goniometer is a valid and reliable tool for measuring joint range of motion in individuals. In this study, digital goniometer; C1-C2 Flexion-Rotation Test will be used to evaluate flexion-extension, right and left rotation neck joint range of motion.
5 minutes
Pain Pressure Threshold Measurement
Time Frame: 5 minutes
Pain pressure threshold measurement will be performed to assess pain sensitivity and determine pressure perception. The algometer is the gold standard tool for pain pressure threshold measurement. In this study, pressure pain threshold assessment will be performed on the trapezius muscle and suboccipital muscles on the affected side of the patients.
5 minutes
Diary
Time Frame: 3 minutes a day
The diary helps both users and healthcare professionals assess the impact of headaches, make diagnoses, and inform healthcare decision-making. In this study, a headache diary will be used to assess patients' headache intensity, frequency, duration, and medication use.
3 minutes a day
Neck Disability Index
Time Frame: 10 minutes
Neck Disability Index is a ten-part test that determines how neck pain affects daily living activities. The Neck Disability Index is a self-scored disability instrument used in patients with cervical musculoskeletal disorders but is increasingly being used to assess neck pain-related disability in individuals with headaches. In this study, NDI will be used to evaluate how patients' neck problems affect their daily living activities. The minimum score is 0, maximum score is 100. High scores show worse results, while low scores show better results.
10 minutes
Postural Examination
Time Frame: 3 minutes
Anterior translations of the head or shoulder may contribute to pain in the upper half of the body. In this study, head and neck translations will be evaluated by measuring the wall-tragus distance and the craniovertebral angle (C7-tragus horizontal angle). Optimal angle of the craniovertebral angle is 48-50.
3 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 13, 2024

Primary Completion (Actual)

February 1, 2026

Study Completion (Actual)

February 18, 2026

Study Registration Dates

First Submitted

November 13, 2024

First Submitted That Met QC Criteria

November 13, 2024

First Posted (Actual)

November 15, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervicogenic Headache

Clinical Trials on Myofascial Release Technique

Subscribe